[Wolfram syndrome].
Oka
Yoshitomo
Y
Division of Molecular Metabolism and Diabetes, Tohoku University Graduate School of Medicine.
D000818:Animals; D003937:Diagnosis, Differential; D006801:Humans; D007004:Hypoglycemic Agents / Q000627:therapeutic use; D007328:Insulin / Q000627:therapeutic use; D007333:Insulin Resistance; D008565:Membrane Proteins / Q000235:genetics; D009154:Mutation; D011379:Prognosis; D012519:Sarcoplasmic Reticulum; D013312:Stress, Physiological; D014667:Vasopressins / Q000627:therapeutic use; D014929:Wolfram Syndrome / Q000175:diagnosis / Q000235:genetics / Q000503:physiopathology / Q000628:therapy
D007004:Hypoglycemic Agents; D007328:Insulin; D008565:Membrane Proteins; C114987:wolframin protein; D014667:Vasopressins